The QualityStocks Daily Wednesday, September 2nd, 2020

Today's Top 3 Investment Newsletters

QualityStocks (JKSM) +205.56%

MarketClub Analysis (CORT) +58.45%

BUYINS.NET (NNVC) +42.35%

The QualityStocks Daily Stock List

Cartier Resources, Inc. (ECRFF)

StocksCafe, Junior Mining Network, OTC Markets, Visual Capitalist, Gold Stock Data, Invezz.com, 24hgold, Nasdaq, Ceo.ca, Macroaxis, Dividend Investor, AA Stocks, Dividend.com, TMXmoney, FX Empire, Wallet Investor, Market Screener, Stockwatch, Dividata, Barchart, GuruFocus, MarketWatch, GlobeNewswire, Newsfilecorp, Seeking Alpha, Central Charts, TradingView, Stockwatch, and Stockhouse reported previously on Cartier Resources, Inc. (ECRFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cartier Resources, Inc. engages in the acquisition and exploration of mining properties in Canada. The Company explores for gold deposits and its flagship project is the Chimo Mine Property. The Chimo Mine Property is held 100 percent by Cartier Resources. Founded in 2006, Cartier Resources is based in Val-d'Or, Quebec. The Company’s shares trade on the OTC Markets.

Pertaining to the Chimo Mine Project, work completed by Cartier Resources includes a total of 121 drill holes for 55,890 m and 20,792 gold samples collected. The Resource Estimate (gold price of US $ 1,300 per ounce and a cut-off grade of 2.5 g/t Au) is 4,017,600 tonnes at an average grade of 4.53 g/t Au for a total of 585,190 ounces gold in the Indicated category; and 4,877,900 tonnes at an average grade of 3.82 g/t Au for a total of 597,800 ounces gold in the Inferred category.

Work is in progress to increase resources at the Chimo Mine Project. This includes a total of 10,000 m of drilling on the 5B4-5M4-5NE and 5CE Gold Zones. In addition, work includes four internal engineering studies and an industrial sorting study of the mineralization. Work also includes an update of the property resources from the results of these initiatives.

In June of this year, Cartier Resources announced that it filed on SEDAR the technical report titled “NI 43-101 Technical Report and Mineral Resource Estimate for the Central, North and South Gold Corridors on the Chimo Mine Project, Quebec, Canada”, bearing the date of signature of June 16, 2020. The NI 43-101 compliant report, completed by InnovExplo, Inc. and GeoPointCom Inc. for Cartier Resources, includes the mineral resource estimate for the Central, North, and South Gold Corridors of the Chimo Mine Property along the Larder Lake – Cadillac Fault.

In August 2020, Cartier Resources announced an interval of 20.4 g/t Au over 2.0 m included within 18.0 m at 2.7 g/t Au, intersected 200 m below the resources of Zones 5B4-5M4-5NE that were estimated by GeoPointCom in 2019. An intersection grading 11.9 g/t Au over 1.6 m, included within a mineralized intersection of 14.6 m at 3.1 g/t Au, and an intersection grading 7.5 g/t Au over 2.5 m, included within a mineralized intersection of 13.7 m at 3.2 g/t Au, were also intersected in Zone 5B4.

Mr. Philippe Cloutier, President and Chief Executive Officer of Cartier Resources, said, “The results from Cartier’s 124 drill holes totalling 58,054 m, along with the results of two completed internal engineering studies and two others still underway, have provided robust information which support our vision of potential scenarios for economic development.”

Cartier Resources, Inc. (ECRFF), closed Wednesday's trading session at $0.23693, up 2.4341%, on 136,342 volume with 32 trades. The average volume for the last 3 months is 71,470 and the stock's 52-week low/high is $0.046300001/$0.300000011.

CloudMD Software & Services, Inc. (DOCRF)

Wall Street Reporter, Wallet Investor, MarketWatch, Stockhouse, InvestorsHub, Barchart, Market Screener, Nasdaq, Canadian Insider, Stockwatch, Streetwise Reports, Dividend.com, Proactive Investors, OTC Markets, GlobeNewswire, TMXmoney, GuruFocus, and Seeking Alpha reported earlier on CloudMD Software & Services, Inc. (DOCRF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A telemedicine company, CloudMD Software & Services, Inc. is working to revolutionize the delivery of healthcare to patients. It is digitizing the delivery of healthcare through providing patients access to all points of their care from their phone, tablet or desktop computer. The Company previously went by the name Premier Health Group, Inc. It changed its corporate name to CloudMD Software & Services, Inc. in February of this year. Incorporated in 2013, the Company has its head office in Vancouver, British Columbia. CloudMD Software & Services lists on the OTC Markets.

The Company provides SAAS (Software as a Service) based health technology solutions to medical clinics throughout Canada. It has developed proprietary technology that delivers quality healthcare via the combination of connected primary care clinics, telemedicine, as well as artificial intelligence (AI). At present, CloudMD Software & Services provides service to a combined ecosystem of 376 clinics, more than 3,000 licensed practitioners, and close to 3 million patient charts across its servers.

The Company has developed a unique healthcare application. This application enables and supports physicians in the longitudinal care of their patients’ health. CloudMD’s patient centric emphasis places the power back in the hands of patients by way of a personalized health record that stores, manages, and enables sharing of health information. Its patients will have increased access to their charts, lab results, the ability to securely chat with clinical staff, reorder prescriptions, and share remote health monitoring data with their doctor.

In August, CloudMD Software & Services announced that it entered into a Binding Term Sheet to acquire Re:Function Health Group, Inc. Re:Function is a foremost rehabilitation clinic network, with 7 clinics and 35 specialists and allied health professionals across the Province of British Columbia. The acquisition represents a major addition to the depth and spectrum of healthcare services provided by the CloudMD platform. With Re:Function, CloudMD’s network will include 14 clinics serving about 500,000 patients.

Re:Function is a state-of-the-art rehabilitation center built by like-minded health professionals providing first-rate patient focused care, with a longitudinal approach to healthcare delivery. The practice is made up of four key rehabilitation pillars. These are Re:Build (physio), Re:Think (counselling), Re:View (medlegal), and Re:Tool (occupational), and a team of specialists. These specialists include Occupational Therapists, Physiotherapists, Kinesiologists, Psychologists, Psychiatrists, and Counsellors.

CloudMD Software & Services, Inc. (DOCRF), closed Wednesday's trading session at $1.35, up 12.50%, on 2,619,748 volume with 1,978 trades. The average volume for the last 3 months is 389,583 and the stock's 52-week low/high is $0.195899993/$1.30999994.

Graphite One, Inc. (GPHOF)

Junior Mining Network, GlobeNewswire, Stock Gumshoe, Stock of the Week, Beat Penny Stocks, FX Empire, Energy and Gold, TipRanks, Make Penny Stocks Great Again, YCharts, Proactive Investors, GuruFocus, Simply Wall St, Mining News North, Dividend Investor, TradingView, Mining News Feed, InvestorIntel, Stockhouse, OTC Markets, WallStreetAlerts.org, Investing News, Green Leaf Pot Stocks, Seeking Alpha, Mining.com, InvestorsHub, and Wallet Investor reported previously on Graphite One, Inc. (GPHOF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Graphite One, Inc. is exploring, with the intent to develop its Graphite One Project, where it could potentially become the dominant American producer of high grade Coated Spherical Graphite (CSG), which is integrated with a domestic graphite resource. The Project is proposed as a vertically integrated enterprise to mine, process, and manufacture high grade graphite mainly for the electric vehicle lithium-ion battery market.

The Company formerly went by the name Graphite One Resources, Inc. It changed its corporate name to Graphite One, Inc. in February of 2019. Founded in 2006, Graphite One is based in Vancouver, British Columbia. Its shares trade on the OTC Markets Group’s OTCQB.

According to Graphite One’s Preliminary Economic Assessment (PEA), potential graphite mineralization mined from its Graphite Creek Property is expected to be processed into concentrate at a graphite processing plant. The proposed processing plant would be located on the Graphite Creek Property situated on the Seward Peninsula roughly 60 kilometers north of Nome, Alaska.

CSG and other value-added graphite products would likely be manufactured from the concentrate at Graphite One's proposed graphite product manufacturing facility. Upon the completion of a Feasibility Study (FS), the Company’s intention is to make a production decision. Graphite One (Alaska), Inc., is a wholly-owned subsidiary of the Company. It holds the Property and is developing the Project in Alaska.

At the end of June 2020, Graphite One announced that it notes recent policy developments in the U.S. Congress and Executive Branch on Critical Minerals, including graphite. On June 24, 2020, the U.S. Senate Committee on Energy & Natural Resources (ENR) held a hearing titled "Impacts of COVID-19 on Critical Minerals Supply Chains." The Senate hearing took place a number of weeks after two Presidential Executive Orders expanded U.S. Federal policy on strategic and critical minerals ranging from a review of Federal project permitting to making critical minerals projects eligible for Defense Production Act Title III loan programs.

Mr. Anthony Huston, Graphite One Chief Executive Officer, said, "There is no reason for the U.S. to be 100 percent import-dependent for graphite and other critical minerals essential to 21st Century technology requirements. This sharpened focus on U.S. supply chains underscores the importance of our Graphite Creek project and our mine-to-material plan to establish a long term source of natural graphite and advanced materials graphite processing in the United States."

Graphite One, Inc. (GPHOF), closed Wednesday's trading session at $0.39, off by 2.50%, on 39,269 volume with 23 trades. The average volume for the last 3 months is 42,781 and the stock's 52-week low/high is $0.094999998/$0.54361999.

Kentucky First Federal Bancorp (KFFB)

Stocktwits, MarketBeat, TipRanks, Stock Analysis, Financhill, The Stock Market Watch, Finviz, Zacks, ETF Channel, Ceo.ca, AI Stock Finder, Investors Observer, Dividend.com, Seeking Alpha, Market Screener, ETF.com, Simply Wall St, last10k, Annual Reports, Morningstar, GlobeNewswire, NewsQuantified, MarketWatch, Nasdaq, Business Insider, Stockhouse, TMXmoney, GuruFocus, Street Insider, Dividend Investor, MacroTrends, and Dividend Channel reported earlier on Kentucky First Federal Bancorp (KFFB), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Kentucky First Federal Bancorp is the holding company for First Federal Savings and Loan Association of Hazard and First Federal Savings Bank of Kentucky. These provide diverse banking products and services in the State of Kentucky. First Federal Savings Bank of Kentucky serves Frankfort, Danville, and Lancaster, Kentucky.

Kentucky First Federal Bancorp is a subsidiary of First Federal Mutual Holding Company. Incorporated in 2005, Kentucky First Federal Bancorp is headquartered in Hazard, Kentucky. The Company lists on the NasdaqGM.

Kentucky First Federal Bancorp’s deposit products include passbook savings and certificate accounts, checking accounts, as well as individual retirement accounts. Its loan portfolio consists of one-to four-family residential mortgage loans; construction loans; and mortgage loans secured by multi-family property. It also includes non-residential loans that are secured by commercial office buildings, churches, and properties used for other purposes.

The Company’s loan portfolio also includes commercial non-mortgage loans; and consumer loans, including home equity lines of credit, loans secured by savings deposits, automobile loans, and unsecured or personal loans. Furthermore, Kentucky First Federal Bancorp invests in mortgage-backed securities; also and provides insurance products and services.

This past May, Kentucky First Federal Bancorp announced Net Earnings of $240,000 or $0.03 Diluted Earnings per Share for the three months ended March 31, 2020, versus Net Earnings of $207,000 or $0.02 Diluted Earnings per Share for the three months ended March 31, 2019. This represents an increase of $33,000 or 15.9 percent.

Net Earnings were $722,000 or $0.09 Diluted Earnings per Share for the nine months ended March 31, 2020, versus Net Earnings of $512,000 or $0.06 Diluted Earnings per Share for the nine months ended March 31, 2019. This represents an increase of $210,000 or 41.0 percent.

The increase in Net Earnings for the quarter ended March 31, 2020 was mainly because of a decrease in Non-Interest Expense. This was to a certain degree offset by a reduction in Net Interest Income.

Kentucky First Federal Bancorp (KFFB), closed Wednesday's trading session at $6.0803, up 1.0352%, on 1,087 volume with 10 trades. The average volume for the last 3 months is 1,473 and the stock's 52-week low/high is $4.40000009/$8.14680004.

KORE Mining Ltd. (KOREF)

Crux Investor, Resource World, The Prospector News, Metals News, FX Empire, Seeking Alpha, Market Screener, Proactive Investors, Mining.com, Stock Day Media, InvestorX, Dividend.com, GuruFocus, OTC Markets, Stockwatch, Junior Mining Network, Mining Stock Education, Wallet Investor, NS Energy, Dividend Investor, PR Newswire, Ceo.ca, InvestorsHub, Barchart, Newsfilecorp, Streetwise Reports, and Nasdaq reported previously on KORE Mining Ltd. (KOREF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

KORE Mining Ltd. engages in the exploration and development of mineral resource properties. The Company is 100 percent owner of a portfolio of advanced gold exploration and development assets in California and British Columbia. KORE Mining earlier announced a positive Preliminary Economic Assessment (PEA) on its Imperial Project. The Company is exploring to increase its gold resource base. KORE Mining is based Vancouver, British Columbia and lists on the OTC Markets Group’s OTCQX.

KORE Mining is supported by strategic investors Mr. Eric Sprott and Macquarie Bank who, together with the management and Board own roughly 64 percent of the basic shares outstanding. KORE has four 100 percent owned gold projects: two in California (Imperial and Long Valley) and two in British Columbia (FG Gold and Gold Creek).

The Company has two primary value-added channels. One is Exploration - deploying a strategic investment from Mr. Sprott, the Company is exploring at three of its four projects to grow its already large gold resource base. The second value-added channel is Developing Imperial – deploying a strategic investment from Macquarie Bank, KORE Mining released a robust PEA on its flagship Imperial Oxide Gold Project ($343 Million NPV 5% and 44% IRR). Its 100 percent owned Imperial Project is located in California within nine miles of the Mesquite mine (owned by Equinox Gold).

Additionally, the 100 percent owned Long Valley project hosts a large near-surface epithermal gold-silver deposit 2.5 km long that is exposed at surface. Also, the 100 percent owned FG Gold project is situated in the Cariboo region of British Columbia. It is easily accessible by gravel road. Furthermore, KORE Mining’s 100 percent owned Gold Creek project is in the Cariboo region of British Columbia, 8 km northwest of the Spanish Mountain project. Gold mineralization was drilled in 2018.

Recently, KORE Mining announced that it increased its land holding in the Cariboo Gold District of British Columbia by 330 percent. The Company is now the dominant land holder of the southern half of the District with Osisko Gold Royalties Ltd.'s (TSX:OR) Barkerville/Cariboo Gold Project controlling the north. Highlights include a consolidated 1,000 square kilometer land position in the southern Cariboo Gold District.

KORE Mining's claims host 110 km of the Eureka thrust structural trend and the Trend is highly prospective for orogenic gold deposits. It is 100 percent KORE Mining owned.

In August, KORE Mining announced that it started work on a PEA of the Long Valley project situated in Mono County, California. The Company states that engineering is well advanced and results are expected in late Q3 2020. The PEA will scope an open pit mine with heap leach processing of oxide and transition materials.

KORE Mining Ltd. (KOREF), closed Wednesday's trading session at $1.19, off by 3.252%, on 24,581 volume with 51 trades. The average volume for the last 3 months is 177,625 and the stock's 52-week low/high is $0.090800002/$1.48000001.

Onconova Therapeutics, Inc. (ONTX)

Stocktwits, BioPharmCatalyst, Market Chameleon, Alpha Stock News, BioPharma Journal, Webull, Morningstar, YCharts, MacroTrends, Investcom.com, TradingView, MarketBeat, Finviz, Stocknews, Seeking Alpha, GuruFocus, Equity Clock, Market Screener, Proactive Investors, Investors Observer, Finbox, Stockhouse, Simply Wall St, GlobeNewswire, TMXmoney, Nasdaq, Investing.com, DBT News, and MarketWatch reported earlier on Onconova Therapeutics, Inc. (ONTX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A biopharmaceutical company, Onconova Therapeutics, Inc. concentrates on discovering and developing novel products to treat cancer. It has a pipeline of proprietary targeted agents designed to work against specific cellular pathways that are important in cancer cells. The Company uses a proprietary chemistry platform. At present, Onconova has a pre-IND (Investigational New Drug) stage program with a CDK4/6 and Ark5 inhibitor, ON 123300. Onconova Therapeutics has its corporate headquarters in Newton, Pennsylvania. The Company’s shares trade on the NasdaqGS.

Clinical trials with Onconova’s compound rigosertib are targeted at what the Company believes are unmet medical needs of patients with cancer. Rigosertib is Onconova’s lead candidate. It is a proprietary small molecule. Preclinical work with rigosertib is underway in COVID-19. Patents covering oral and injectable rigosertib have been issued in the United States and are expected to provide coverage until at least 2037.

The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to numerous years. Additionally, this dosage form may support combination therapy modalities. To date, greater than 400 patients have been dosed with the oral formulation of rigosertib in clinical trials. Moreover, an investigator-initiated Phase 1/2a study in KRAS+ lung adenocarcinoma is continuing.

Selected Q2 2020 developments and recent highlights for Onconova Therapeutics include the pivotal Phase 3 INSPIRE trial reaching the required number of survival events for data analysis. Highlights also include initiation of and first patient enrollment in a Phase 1/2a study exploring an oral Rigosertib plus nivolumab combination in KRAS+ lung cancer patients. The Company submitted applications for Rigosertib to participate in federally funded human studies in COVID-19 disease based on early-stage preclinical evidence of Rigosertib inhibition of SARS-COV-2 replication.

In August, Onconova Therapeutics announced that INSPIRE, its pivotal Phase 3 study assessing the efficacy and safety of IV Rigosertib in higher-risk MDS (HR-MDS) patients, did not meet its primary endpoint of improved survival.

Mr. Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova Therapeutics, said, “Onconova would like to thank the MDS community for its participation in the INSPIRE trial. We report these results with great disappointment, and we remain deeply indebted to every patient, physician, and family member involved in the study.

Onconova is fortunate to have built a product pipeline that includes multiple promising agents, including oral rigosertib and ON 123300. Both compounds target meaningful cancer pathways, and we look forward to further efforts with these programs. The Company will review pipeline and in-licensing opportunities both internally and with external advisors.”

Onconova Therapeutics, Inc. (ONTX), closed Wednesday's trading session at $0.2277, up 3.6885%, on 28,971,724 volume with 22,390 trades. The average volume for the last 3 months is 19,695,052 and the stock's 52-week low/high is $0.102700002/$2.83999991.

SiNtx Technologies, Inc. (SINT)

Stocktwits, Zacks, trade ideas, Invest Chronicle, Market Chameleon, Investor Place, Nasdaq, Street Insider, Stockopedia, Morningstar, Seeking Alpha, ChartMill, DBT News, Stockhouse, NasdaqTrader, Finviz, Investing.com, ADVFN.com, Market Screener, Simply Wall St, ETF.com, Webull, Investors Observer, Dividend.com, GlobeNewswire, TMXmoney, GuruFocus, Barchart, Business Insider, YCharts, and MacroTrends reported earlier on SiNtx Technologies, Inc. (SINT), and today we report on the Company, here at the QualityStocks Daily Newsletter.

SiNtx Technologies, Inc. is an original equipment manufacturer (OEM) ceramics enterprise. The Company’s emphasis is on silicon nitride and its applications. SiNtx develops and commercializes silicon nitride for medical and non-medical applications. The Company formerly went by the name Amedica Corporation. It changed its name to SiNtx Technologies, Inc. in October of 2018. Founded in 1996, SiNtx Technologies lists on the NasdaqGS. The Company has its head office in Salt Lake City, Utah.

SiNtx’s commitment is to the advancement of high-tech ceramics in numerous industries. The core strength of the Company is the manufacturing, research, and development of silicon nitride ceramics for external partners.

SiNtx Technologies manufactures silicon nitride material and components in its FDA (Food and Drug Administration) registered and ISO 13485 certified facility. Silicon nitride has been identified as a solution in areas including the Biomedical Field; Aerospace, Defense, and Transportation.

Currently, SiNtx is manufacturing silicon nitride and SN-Peek. SINTX SN (Silicon Nitride)-PEEK composite combines the innovative and beneficial bioactivity of silicon nitride with the familiar fit, feel, and processing properties of conventional polyetheretherketone (PEEK) polymer. The production of the material is by compounding an extremely fine particulate form of SINTX MC2 Si3N4 bioceramic into an implant grade PEEK matrix.

SiNtx Technologies is the exclusive manufacturer of silicon nitride spinal implants for CTL-Amedica. SiNtx has had success with the development of the Micro-composite ceramic (MC2) silicon nitride material for spinal implants. As a result, the Company is looking to broaden the application of this unique material to other medical device applications. A key area of focus for the MC2 material is for dental implants.

In August, O2TODAY announced that it entered into a joint development agreement with SiNtx Technologies. The objective of the agreement is to develop a safe and effective consumer facemask with broad-spectrum antibacterial and antiviral activity, based on incorporating SiNtx’s inventive silicon nitride powder into the mask filter and fabric.

O2TODAY is an original equipment manufacturer (OEM) company. O2TODAY develops and commercializes face masks for medical and non-medical applications. The successful development of such a product may help prevent the spread of respiratory diseases through catching and inactivating SARS-CoV-2 and other viruses and bacteria in the mask itself before they can enter into the human body.

Dr. Sonny Bal, Chief Executive Officer, and President of SiNtx Technologies, said, “The collaboration with O2TODAY is intended to directly apply our material science expertise toward new product development, and revenues - a very significant and exciting move for SiNtx. We look forward to sharing more information on the testing, productization, and distribution of facemasks incorporating SiNtx’s silicon nitride in the coming months.”

SiNtx Technologies, Inc. (SINT), closed Wednesday's trading session at $1.755, up 7.0122%, on 4,663,574 volume with 10,840 trades. The average volume for the last 3 months is 10,042,952 and the stock's 52-week low/high is $0.280000001/$3.29999995.

AVRA Medical Robotics, Inc. (AVMR)

Wall Street Reporter, Financial Buzz, EODData, TipRanks, VentureLine, last10k, GuruFocus, Market Screener, BioSpace, Global Banking and Finance, Seeking Alpha, Wallet Investor, Stockhouse, OTC.Watch, GlobeNewswire, MarketWatch, Nasdaq, Dividend Investor, Market Wire News, Dividend.com, Stockopedia, TradingView, Simply Wall St, and TMGPulse reported beforehand on AVRA Medical Robotics, Inc. (AVMR), and today we are reporting the Company, here at the QualityStocks Daily Newsletter.

AVRA Medical Robotics, Inc. is building a fully autonomous medical robotic system through the use of new technologies combining artificial intelligence (AI), machine learning and proprietary software. The OTCQB-listed Company is modernizing the practice of surgery by developing a fully autonomous medical robotic system that “robotizes” a wide spectrum of medical procedures now being performed by human hands utilizing surgical and non-surgical devices and instruments. AVRA Medical Robotics has its corporate office in Orlando, Florida.

AVRA’s medical team were among the earliest adopters to perform robotically assisted, minimally-invasive surgery. The Company’s Surgeons are partnering with engineers and scientists to design and develop a novel, computer-integrated, semi/autonomous robotic platform that is truly disruptive. AVRA is designing systems that will enable surgeons to simulate procedures for preoperative review before performing surgery.

Regarding Imaging, AVRA Medical Robotics’ imaging technology will be capable of high-resolution, multi-dimensional imaging with incorporated scanning and registration. The Company’s technology will be flexible and applicable across a diverse range of medical disciplines.

Concerning Instrument Guidance, the proprietary intelligent AVRA Instrument Guidance System (AIGS) will bring precise navigation and accurate targeting to robotic surgery. This will result in a Surgeon interfaced autonomous platform. Furthermore, AVRA is using its technology to develop ways of considerably improving biopsy result waiting times from weeks or days to minutes.

Recently, AVRA Medical Robotics announced that it paid off almost all of its external corporate debt, including accrued interest. With the exception of loans from the Chief Executive Officer (CEO) and a loan note for $25,000 due December 31, 2020, AVRA has now cleared all its outstanding external debt, with one note of $25,000 being converted into shares at $1.50 per share and the remainder being repaid in full with accrued interest.

Mr. Cohen, AVRA CEO, said, “The repayment of all this Company debt provides further stability to the company’s finances, allowing us to focus on our medical software procedure program and the development of our Autonomous Robotics Surgical System. The potential of our robotic systems is to perform operations with greater precision than human hands are capable of.”

AVRA Medical Robotics, Inc. (AVMR), closed Wednesday's trading session at $0.59, up 151.0638%, on 3,038 volume with 4 trades. The average volume for the last 3 months is 6,211 and the stock's 52-week low/high is $0.109999999/$2.25.

Jacksam Corporation (JKSM)

StockAP, OTC.Watch, Stockopedia, Real Investment Advice, Stockwatch, Simply Wall St, Investors Hangout, last10k, GlobeNewswire, Insider Monitor, TradingView, Investors Hub, PR Newswire, and GuruFocus reported previously on Jacksam Corporation (JKSM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Jacksam Corporation is a workflow automation company centered on developing machinery and equipment solutions for the cannabis and CBD (cannabidiol) industry. The Company designs and markets proprietary automated vape, POD and cartridge filling/capping equipment for the cannabis industry. It serves the medical cannabis, hemp, and CBD segments of the e-cigarette and vaporizer markets with its oil vaporizer focused products. Jacksam is based in Rancho Santa Margarita, California. The Company lists on the OTC Markets’ OTCQB.

Jacksam’s automated equipment is designed and built in the USA. It carries the only full UL certification in the U.S. Using Jacksam/Convectium's automated equipment, its customers increase output by up to 60 times over hand filling. Jacksam/Convectium is focused on helping its customers automate their workflow and get custom branded products onto dispensary shelves fast. More than 100 companies, including many dominant brands in the space, rely on Jacksam/Convectium for automation of their filling operations.

The Company has adopted an “open source” business model enabling the majority of cannabis and CBD oil producers to benefit from its filling and capping equipment. Jacksam (shifting away from a closed system approach) has made its vape, POD and cartridge trays and equipment compatible with components produced by most of the top international manufacturers.

This past December, Jacksam announced that The Stock Day Podcast welcomed Jacksam Corporation. The President and Chief Executive Officer of the Company, Mr. Mark Adams, joined Stock Day host Everett Jolly. Jolly began the interview by commenting on Jacksam's partnership with Jupiter Research, LLC, and what it means for their future.

Mr. Adams said, "Jupiter is by far the leading C-Cell technology company selling in the United States and abroad. They bring a quality and research and development technology aspect to a partnership that we really value."

They then discussed the Company's revenue potential in 2020. Mr. Adams said, "We did a preliminary test on Jupiter customers, and estimated that there are over 500 customers that we can sell machines to and service together. Our agreement does allow us some royalty revenue. We think that the revenue opportunity is huge." Mr. Adams noted that Jacksam also expects the vaping industry to bounce back this year.

Jacksam Corporation (JKSM), closed Wednesday's trading session at $0.55, up 205.5556%, on 16,412 volume with 21 trades. The average volume for the last 3 months is 18,728 and the stock's 52-week low/high is $0.100000001/$1.14999997.

Celexus, Inc. (CXUS)

Market Screener, Stockopedia, Simply Wall St, TeleTrader, Street Insider, PR Newswire, Invest Tribune, Dividend Investor, Last10k, OTC Markets, Investors Hangout, TradingView, Wallet Investor, Stockwatch, Stockhouse, GlobeNewswire, and InvestorsHub reported previously on Celexus, Inc. (CXUS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Celexus, Inc. is an acquisition, management and holding company for high-trajectory agritech businesses and farming technologies. The OTCQB-listed Company was formerly known as Telupay International, Inc. As of February 2019, Celexus has agreed to acquire HempWave and operate it as a wholly-owned subsidiary. HempWave partners with farmers throughout the nation to grow, cultivate, and harvest commercial-grade hemp plants and seeds to produce medicinal grade cannabidiol (CBD oils) and other hemp by-products. Celexus is based in Arizona.

Fundamentally, Celexus operates as an acquisition, management, and holding company for early stage businesses and technologies in the hemp industry. It works to bring to market the best, most valuable innovations in the flourishing industrial hemp space. Celexus is actively assessing new acquisition candidates across the agriculture industry.

The Company’s aim is to control every aspect of the farming industry. This is from seeds to extraction and distribution. This eliminates reliance on third parties and ensures premier quality processes and production.

At the end of October, Celexus announced its new research and development division. In combination with small businesses and entrepreneurs, the Company is developing proprietary software using blockchain algorithms specific to the complexities of hemp biomass transactions. Additional technology in development includes drone mapping, soil nutrition, and data analytics, among others.

Celexus is investing in the technologies that will move agriculture, especially industrial hemp, into a growth market with far-reaching economic and environmental impact. This is to support its mission of growing a sustainable future.

At the end of December, HempWave announced its intention to purchase a controlling interest in Celexus from the present majority shareholders of Celexus. Celexus would subsequently change it’s name to Hempwave and become the brand of operations. The existing Hempwave will continue independent operations and would vend in new businesses into Celexus over a period of time. The deal is scheduled to close at the annual Shareholders meeting in Las Vegas, Nevada in May 2020.

Central to HempWave’s differentiated approach is the crop buyback program, announced earlier in 2019, in which HempWave guarantees a floor price based on CBD concentration percentage of the harvested biomass, up to current spot price, whichever is higher at the time. This policy solves for issues of uncertainty or potential loss, major obstacles in the ever-developing hemp market.

Celexus, Inc. (CXUS), closed Wednesday's trading session at $0.02, up 1900.00%, on 150 volume with 1 trade. The average volume for the last 3 months is 95 and the stock's 52-week low/high is $0.001/$0.949999988.

Northwest Biotherapeutics, Inc. (NWBO)

RedChip,  Promotion Stock Secrets, OTC Picks, Wall Street Corner, BUYINS.NET, StockPicksNYC,  INO.com Market Report, Wealth Makers, SmallCapVoice, Wealthpire, Cool Penny Stocks, Street Insider, Pure Action Stocks, Pennybuster, The Street, FeedBlitz, All Penny Stocks,  Bull Rally, Marketbeat, Investor Place, and Streetwise Reports reported earlier on Northwest Biotherapeutics, Inc. (NWBO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Northwest Biotherapeutics, Inc. is a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers. In the United States and Europe, the Company’s concentration is on developing personalized immunotherapy products, on a cost-effective basis, designed to treat cancers more effectively than contemporary treatments. This is without toxicities of the kind associated with chemotherapies. Northwest Biotherapeutics is based in Bethesda, Maryland and the Company lists on the OTCQB.

Northwest Biotherapeutics has a broad platform technology for DCVax dendritic cell-based vaccines. The Company is working to move ahead with numerous clinical programs, involving DCVax-L and DCVax-Direct. Northwest’s lead program is a 331-patient Phase III trial in newly diagnosed Glioblastoma multiforme (GBM). This trial has completed its enrolment.

The Company is pursuing completion of the current Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer and pursuing Phase II combination trials of DCVax-L and checkpoint inhibitor drugs. This includes the Phase II trial of DCVax-L and Pembrolizumab (Keytruda) for colon cancer that was previously announced.

Northwest’s product candidates also include DCVax-Prostate. The design of this product is specifically for late stage, hormone independent prostate cancer. The Company has developed a DCVax product line using a particular proprietary antigen — PSMA (Prostate Specific Membrane Antigen). The PSMA is produced via recombinant manufacturing methods. It is subsequently combined with the fresh, personalized dendritic cells to make DCVax-Prostate.

Northwest Biotherapeutics received clearance from the Food and Drug Administration (FDA) for a 612-patient Phase III trial in prostate cancer. It received approval in Germany of a five-year Hospital Exemption for the treatment of all gliomas (primary brain cancers) outside the clinical trial. It is also pursuing a Phase I/II trial with DCVax-Direct for all types of inoperable solid tumor cancers. It completed the 40-patient Phase I portion of the trial. Northwest is preparing for Phase II portions.

Recently, Northwest Biotherapeutics announced that it hired Mr. David Innes as Vice President, Investor Relations. Mr. Innes comes to the Company with more than 31 years of managing portfolios at major Wall Street firms, and a degree in biology.

Mr. Innes said, "After decades of focusing on small to mid-cap biotech and biomedical companies, I was attracted to NW Bio by what I believe is their broad potential, due to their approach to addressing the complexity of solid tumors which comprise most cancers. Their DCVax technology is precision-tailored to a patient's cancer, while also designed to mobilize a broad-spectrum attack on the cancer. As such, I believe NW Bio's DCVax technology has the potential to be a meaningful therapy for many types of solid tumor cancers."

Northwest Biotherapeutics, Inc. (NWBO), closed Wednesday's trading session at $0.5504, up 35.0675%, on 24,146,923 volume with 4,876 trades. The average volume for the last 3 months is 2,382,166 and the stock's 52-week low/high is $0.14/$0.600000023.

Invictus MD Strategies Corp. (IVITF)

NetworkNewsWire, Tip Ranks, The Street, Dividend Investor, GuruFocus, Pot Network, Emerging Growth, Profit Confidential, Insider Financial, Penny Stock Tweets, Stockhouse, Market Screener, OTC Markets, Investing News, YCharts, Daily Marijuana Observer, CapitalCube, Barchart, Equities, Financial Content, Midas Letter, InvestorsHub, Wallet Investor, and MarketWatch reported earlier on Invictus MD Strategies Corp. (IVITF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Invictus MD Strategies Corp. is a global cannabis company based in White Rock, British Columbia. Invictus offers a selection of products under a wide range of lifestyle brands. The Company and its subsidiaries primarily engage in the investment, acquisition, and development of synergistic businesses in the medical cannabis industry in Canada. Invictus MD Strategies lists on OTC Markets’ OTCQX.

Invictus’ commitment is to providing patients and adult users with high-quality medical-grade cannabis. It represents a strong platform of licensed cannabis producers across Canada. The Company has secured one of the strongest cultivation profiles in Canada, supported by more than 250 acres of production capacity. Through more than 50,000 kgs by 2021. Invictus supports its growers with state-of-the-art production and processing facilities.

Invictus MD Strategies’ portfolio includes Acreage Pharms Ltd. (West-Central Alberta – 100 percent Ownership); AB Laboratories, Inc. (Hamilton, Ontario – 50 percent Ownership); and AB Ventures, Inc. (Hamilton, Ontario - 33.3 percent Ownership). In addition, its portfolio includes Future Harvest (Kelowna, British Columbia - 82.5 percent Ownership).

Recently, Invictus announced that it entered into a non-binding Letter of Intent (LOI) with GTEC Holdings Ltd. for the acquisition by Invictus of all of the issued and outstanding shares in the capital of GTEC in an all-share transaction valued at roughly $100 million, forming Western Canada's largest indoor vertically integrated cannabis companies. The combined entities would provide a vertically integrated cannabis company, centered on producing premium flower and complementary product portfolio, cultivated in purpose-built indoor facilities complemented with first-class genetics.

Mr. George E. Kveton, Invictus MD Strategies’ Chief Executive Officer, said, "We have been pleased with the continued execution of the team and business strategy at GTEC. The dedication to producing a premium product medical and adult-use recreational portfolio for the industry has always been our relentless pursuit. This merger allows for both companies to leverage the combined core competencies to further execute our vision to be at the forefront of the Canadian cannabis industry and beyond."

Invictus MD Strategies Corp. (IVITF), closed Wednesday's trading session at $0.015, up 50.00%, on 136,731 volume with 23 trades. The average volume for the last 3 months is 112,973 and the stock's 52-week low/high is $0.000099999/$0.275799989.

Natcore Technology, Inc. (NTCXF)

Stockhouse, InvestorsHub, MarketWatch, OTC Markets, Business Insider, and StreetInsider reported on Natcore Technology, Inc. (NTCXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Natcore Technology, Inc. concentrates on using its proprietary Foil Cell technology to considerably lower the costs and improve the power output of solar cells. The Company is creating the next generation of solar cells. Natcore is developing two main technologies. These are low-cost, all-back-contact solar cell structures, and Black Silicon cells.

A solar R&D company, Natcore Technology is headquartered in Rochester, New York. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s Foil Cell (All Back Contact Solar Cell) uses a high-speed, low temperature laser process. Natcore’s Black Silicon technology streamlines the path to low solar cell reflectance.

Natcore Technology has its Natcore Laboratory in Rochester. This is a 19,000 sq. ft. facility. It has 8,000 sq. ft. of ‘class 10,000’ clean room. The Company engages in the full solar cell process at this laboratory - from bare silicon wafer to working cells.

Regarding the Company’s Foil Cell Structure, the process involves multilayer foil metallization. Key features/properties include low cost contact metals and simplified manufacture. This includes low capital equipment cost, small factory footprint, and low temperature processing.

Natcore Technology has established exclusive licenses and/or joint research agreements with Rice University, the National Renewable Energy Laboratory (NREL), Fraunhofer ISE and the University of Virginia. The Company has received 33 patents; 32 patents are pending.

Recently, Natcore Technology announced it significantly streamlined the fabrication method for its pioneering Natcore Foil Cell™. This allows for even lower-cost production methods.

The Company is targeting greater than 25 percent real-world efficiency for its eventual production solar cells. This is approximately a 25 percent performance improvement over numerous high-end commercial cells being installed today.

The use of laser processing to create the Company’s unique, all-back-contact cell structure has been eliminated and replaced by a carrier selective contact process. This is combined with a foil metallization, which can be inexpensively made with high-speed roll-processing methods. Natcore has started an accelerated development program to produce a prototype with the new process, and also include production cost and efficiency modeling by independent authorities.

Natcore Technology, Inc. (NTCXF), closed Wednesday's trading session at $0.0035, up 66.6667%, on 2,830 volume with 1 trade. The average volume for the last 3 months is 35,158 and the stock's 52-week low/high is $0.00075/$0.0285.

Enertopia Corp. (ENRT)

Penny Stock General, Shiznit Stocks, Cannabis Financial Network News, PennyStocks24, Fast Money Alerts, Stock Shock and Awe, Penny Champions, Equities.com, MassiveStockProfits, Wall Street Equities Research, Stockgoodies, GrowthPennyStocks, and Penny Dreamers reported earlier on Enertopia Corp. (ENRT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Enertopia Corp. is exploring a portfolio of three prospective lithium projects in the State of Nevada. Additionally, at the same time, the Company is working with water purification technology believed to be able to recover Lithium from brine solutions. Enertopia has its corporate office in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

Enertopia announced in April 2017 the formation of a Lithium business division for the exploration of Lithium. In May 2017, it closed the definitive agreement for the Lithium exploration project in Nevada.

In June 2017, Enertopia announced its Surface Exploration Program in Nevada. In Nevada, the Company has 2,560 acres of placer mining claims staked in Edwards, Smith and Big Smoky valleys.

The Central Nevada Lithium Brine Projects are proximal to an existing lithium mine. There is all weather access on paved roads and it is an ideal evaporation climate.

Genesis Water Technologies (GWT) is a partner of Enertopia. GWT is a manufacturer of advanced, innovative and sustainable treatment solutions for applications in process water, drinking water, water reuse and waste water for the energy, agriculture processing, industrial, municipal infrastructure, and building/hotel sectors.

Since September 2017, GWT has been evaluating data obtained from the first bench test results and other technical data provided by Enertopia to complete a larger and enhanced lithium recovery system. This $200,000 pre-paid second phase bench test is now complete. The second phase of the second bench test will use synthetic brine solutions, which will be created from the surface samples from the two bulk samples taken at Enertopia’s Clayton Valley project.

The next steps for the Company in 2018 are a bench test build out this month and preparation of synthetic brines in February. In March and April, bench testing of synthetic lithium brines will take place. In May will be final laboratory lithium recovery and Li2CO3 grade results.

Enertopia Corp. (ENRT), closed Wednesday's trading session at $0.0122, up 33.3333%, on 887,109 volume with 27 trades. The average volume for the last 3 months is 218,677 and the stock's 52-week low/high is $0.0023/$0.063000001.

The QualityStocks Company Corner

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) was highlighted today in a publication from MiningNewsWire, examining how DeepGreen Metals, a start-up from Canada intent on extracting battery metals such as manganese, cobalt, copper and nickel from the bottom of the sea, has partnered up with various universities as well as scientific research institutions on its deep-sea exploration program. This will help the company characterize the possible effects of mining polymetallic ore from the Pacific Ocean’s Clarion-Clipperton Zone (“CCZ”).

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon-free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

 

Energy Fuels Inc. (UUUU), closed Wednesday's trading session at $1.92, up 1.0526%, on 1,826,859 volume with 5,499 trades. The stock's 52-week low/high is $0.779999971/$2.3499999.

Recent News

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced that company executives will be presenting at LD Micro’s elite LD 500 Virtual Investor Conference. The presentation is scheduled for Wednesday, Sept. 2, 2020, at 3:40 p.m. ET. An archived copy of the webcast will be available for 90 days following the live presentation. To watch the live webcast of the presentation, visit http://ibn.fm/QS1EB. To view the full press release, visit http://ibn.fm/Pcn1n.

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Wednesday's trading session at $0.9296, up 0.172414%, on 472,209 volume with 854 trades. The average volume for the last 3 months is 979,763 and the stock's 52-week low/high is $0.839999973/$6.25.

Recent News

LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF)

The QualityStocks Daily Newsletter would like to spotlight LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF).

LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) was featured today in a publication from BioMedWire, examining how, with the increase in demand for Personal Protective Equipment as well as other medical supplies, especially for the frontline workers who risk their lives every day during this pandemic period, many well-meaning innovators around the world have taken this up as an opportunity to help out by making this equipment readily available. These include nasal swabs, 3D-printed face shieldsventilator machines as well as open-source oxygen concentrator.

LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) is a molecular diagnostics company that develops genetic analyzers for rapid detection of pathogens at the point-of-need.

Based in the greater-Boston, Massachusetts area, the company’s fully automated genetic analyzer for pathogen detection, the MiQLabâ„¢, is designed to deliver reference-quality data with ease of use. MiQLab’s technology screens samples for up to 27 different targets at once—looking for pathogens and antimicrobial resistance factors—and returns results in approximately one hour. It is designed to be operated at the site of sample collection to avoid the delay associated with shipping and manually processing samples. This technology is designed for use in multiple markets, including human and veterinary diagnostics, as well as food safety testing ($12.9B, $2.2B, and $23.4B markets, respectively).

Portfolio Benefits

Rapid, automated pathogen detection

LexaGene’s MiQLab pathogen detection system offers rapid and sensitive testing to markets in need of better vigilance against pathogens that could endanger health and harm public safety and the bottom line. The company’s disruptive technology is on-demand and offers results in approximately an hour.

End users collect a sample, load it onto the MiQLab genetic analyzer with a sample preparation cartridge, enter a sample ID and press ‘go’.

MiQLab is open-access, which allows users to easily customize their own tests, in addition to running the company’s own validated tests. No comparable technology exists on the market today for automating customized testing. The open-access market is over $20 billion in value and includes industries like pharma and biotech that currently need an automated method of performing PCR testing in a cost-efficient way.

Improved COVID-19 Testing

As the COVID-19 pandemic continues to pose a threat to global safety, the need for improved testing procedures has been well established. LexaGene’s technology is automated and designed to be used at the point-of-need, thereby avoiding the 12- to 24-hour shipping time. Plus, it performs sample preparation and the gold standard RT-PCR chemistry for exceptional data quality in about one hour.

Because LexaGene’s open-access instrument can be rapidly configured to detect novel pathogens, it is ideally suited to prevent pandemic spread with its easily deployed testing that facilitates rapid quarantine-related decision making.

This speed is in stark contrast to competitor point-of-care technologies that have reagents pre-embedded into complex and expensive cartridges that are only manufactured at specialized production sites – making it impossible to rapidly meet a swift increase in demand.

According to Dr. Jack Regan, LexaGene’s CEO and founder, the world needs easy-to-use, fully automated pathogen detection instruments operating at points-of-need that can be equipped with tests to detect a novel pathogen within a week of knowing its genetic sequence. For this pandemic, the lack of such technology forced the majority of testing to occur in distant reference laboratories, making rapid decisions on quarantine impossible and making the likelihood of successful containment remote.

Regan explained in a press release (http://nnw.fm/Vz5Ju), “LexaGene expects to be the first company to commercialize an automated open-access microfluidic technology designed for use at the point-of-need that can be configured to detect a novel pathogen in just a week’s time of its emergence – for use on-site to return results in one hour – and improve our chances of successful containment.”

Market Potential

LexaGene’s technology has a wide range of applications across many other markets, including biotech and pharma testing, water quality monitoring, agricultural testing, biodefense, and use at point-of-need at border crossings, military bases, aircraft carriers and cruise ships.

Markets for customized testing solutions are poised for significant growth. Industry analysts forecast considerable expansion of many of LexaGene’s potential target markets in the coming years, including:

  • The genotyping sector, forecast to reach a valuation of $31.9 billion by 2023;
  • PCR assays, expected to make up a $7 billion market opportunity by 2026;
  • The sample prep market, forecast to eclipse $9.3 billion by 2025;
  • Water quality monitoring, set to grow to $1.59 billion by 2022; and
  • Agricultural testing, anticipated to reach $6.29 billion by 2022.

LexaGene’s patented microfluidic system was invented by company CEO Regan, a leading scientist who developed a bio-warfare surveillance instrument that has been adopted by the Department of Homeland Security. Regan is also known for developing an instrument that detects respiratory pathogens from nasal swab samples. The development of these instruments was supported by $20 million in government funding.

Management Team

LexaGene’s experienced leadership team drives company growth with a focus on innovation, pursuing unique market opportunities and providing shareholder value.

Dr. Jack Regan, Chief Executive Officer & Director, is the inventor of the company’s flagship automated pathogen detection technology, the MiQLab. Before founding LexaGene, he led a team of scientists at Bio-Rad Laboratories (NYSE: BIO) in developing tests for detecting pathogens, cancer and neurological disorders using droplet digital PCR. Prior to Bio-Rad, Regan helped QuantaLife, a startup company, bring its product from concept to commercialization, where it was subsequently acquired by Bio-Rad. He has also worked at Applied Biosystems/Life Technologies on automated sample preparation and did his post-doctoral training at Lawrence Livermore National Laboratory. His doctoral training at the University of California San Francisco focused on influenza viral replication.

Daryl Rebeck, President, has over 20 years of capital market experience with an established international financial network. Rebeck was a vice president and senior investment advisor with Canada’s largest independent investment bank, Canaccord Genuity, where he was responsible for raising significant risk capital for growth companies, with a particular focus on natural resources and medical technology. He has since worked to provide management expertise and grow shareholder value. He served as senior VP of corporate finance of Auryn Resources (NYSE: AUG), a $250 million market cap mining exploration company.

Jeffrey Mitchell, CFO, boasts over two decades of financial and SEC experience. Before joining LexaGene, he served as controller and director of finance, overseeing areas such as public company financial reporting, audits, and financial planning and analysis for Palomar Medical Technologies Inc. In addition to his many years at Palomar, Mitchell has served in numerous financial and strategic advisory roles for medical device, imaging and diagnostic companies.

LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF), closed Wednesday's trading session at $0.6598, up 0.291847%, on 351,749 volume with 94 trades. The average volume for the last 3 months is 363,815 and the stock's 52-week low/high is $0.303799986/$0.928245007.

Recent News

Pac Roots Cannabis Corp. (CSE: PACR)

The QualityStocks Daily Newsletter would like to spotlight Pac Roots Cannabis Corp. (PACR).

Pac Roots Cannabis Corp. (CSE: PACR) was featured today in the 420 with CNW by CannabisNewsWire. Congressional leadership announced formally on Friday that the House would vote on a cannabis legalization bill in September. James Enos Clyburn, the Majority Whip (D-SC) confirmed in a mass email to members that the chamber is expected to debate the MORE Act (Marijuana Opportunity, Reinvestment and Expungement) in the September period. This is despite the floor vote having not yet been scheduled.

Pac Roots Cannabis Corp. (CSE: PACR) is a Canadian cannabis company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach.

The company began operations in 2012, with activities primarily directed toward exploration and development of mineral properties in Canada. Today, it is focused on cannabis and hemp cultivation, leveraging high-end genetics and specialized cultivars to produce top quality products. Pac Roots has announced multiple promising initiatives in recent months, including its formation of an outdoor premium hemp joint venture with partner Rock Creek Farms in British Columbia, Canada, and its agreement to acquire all issued and outstanding shares of a firm holding 250 acres of land in the famed Fraser Valley Region of British Columbia.

Pac Roots is also in the process of completing its 20,000 square foot cultivation facility in Lake Country, British Columbia. The facility is expected to feature approximately 7,600 square feet of cultivation space that will enable the company to cycle through an elite line of 350+ unique, high-grade cultivars. Pac Roots expects to receive a cultivation license for the facility in the fourth quarter of 2020.

High-End Selectively Bred Genetics

Pac Roots focuses on high-end genetics in order to maximize the quality of its products while maintaining high yields and profit margins.

Through the process of artificial selection, farmers and cultivators have been adapting their plants to develop particular phenotypic traits for generations. Historically, this practice was restricted to underground cannabis producers developing their own strains.

The legalization of the cannabis industry has given producers access to thousands of cultivars located throughout the world while accelerating research into cannabis genetics. By carefully selecting strains, growers can control the size, color, smell, density and texture of cannabis buds, thereby creating distinctive, premium cannabis products.

Plants are bred to thrive in specific growing environments. This maximizes the yield of high-quality, resilient cannabis. Medical cannabis strains can also be tailored for specific medicinal purposes.

A strategic partnership with Phenome One, a plant breeding management and analytics firm, gives Pac Roots access to some of the world’s best cannabis genetics from the largest genetic library in Canada. The company is using these genetics to develop unique strains featuring a variety of beneficial characteristics.

The company’s 350+ licensed live cultivars and over 1,800 seed varieties are the result of a meticulous gene selection process, through which as many as 600 individual plants may be grown to produce a single strain. Selecting optimized genetics in this way provides benefits beyond simply producing a high-end product. In addition to potency and bud quality, cannabis plants are bred for yield and resilience. By selecting genetics that result in larger and more numerous buds on each plant, Pac Roots is able to grow more cannabis per grow light.

Breeding plants to be more resilient also reduces the cost and labor required. These factors, combined with the premium price point associated with top-quality cannabis, have the potential to improve Pac Roots’ overall profit margin.

Partnership with Phenome One

Pac Roots has secured its cultivars through a strategic licensing agreement with Phenome One. Under the agreement, Pac Roots has unlimited access to Phenome One’s live genetic library, including any of Phenome One’s cultivars and its growing, breeding and cloning IP.

Phenome One is an agricultural technology company focused on providing software solutions to seed companies. Phenome One’s platform gives its partners access to a massive database of detailed information on over 350 unique cannabis cultivars to support each stage of the breeding process. Each cultivar has been laboratory analyzed and rigorously field-tested, with data going back more than 30 years.

Using Phenome One’s data, Pac Roots plans to grow a variety of cannabis plants optimized for certain traits. One such trait will be plants with an abundance of cannaflavin, a rare terpene with high anti-inflammatory properties. Phenome One’s library could enable Pac Roots to produce plants that are bred to thrive in a range of different growing climates, including plants suited to grow in cold weather and plants that are resilient to region-specific fungi.

Joint Venture with Rock Creek Farms of British Columbia

Pac Roots recently entered a definitive investment agreement with Rock Creek Farms, a reputable agricultural enterprise, for a 100-acre commercial hemp operation in Rock Creek, British Columbia. The growing space is located in the highly lucrative farming area known as the ‘Golden Mile’ in the South Okanagan Valley of British Columbia. (http://nnw.fm/Gbf9I).

Under the agreement, the two companies have formed an outdoor premium hemp joint venture company to which Pac Roots is providing an aggregate of $450,000 in capital and Rock Creek Farms is contributing two commercial leases for 100+ acres of growing space, along with cultivation licenses, agricultural infrastructure and equipment, consulting services, intellectual property relating to hemp operations and proprietary biomass storage methods. Pac Roots holds a 60 percent interest in the project.

About 127,500 premium hemp CBD seedlings were planted across 100 acres as of early July 2020. The joint venture is planting a premium grade CBD hemp variety utilizing the rich native soil and both traditional and custom farming techniques.

“Our operational partners at Rock Creek Farms bring decades of generational farming expertise in one of Canada’s pre-eminent growing regions,” Pac Roots President and CEO Patrick Elliott said in a news release detailing the venture. “It will be an exciting outdoor growing season for the joint venture as we anticipate a successful harvest in the fall.”

Infinite Development Possibilities at Fraser Valley Property in British Columbia

In mid-July 2020, the company initiated a share purchase agreement with 1088070 BC. LTD. (“1088”) and its shareholders for the acquisition of all issued and outstanding shares of 1088 (http://nnw.fm/xlpw7). Notably, 1088 owns and controls 250 acres of land spread over nine parcels in the Fraser Valley Regional District.

The Fraser Valley Regional District is one of the most productive and intensively farmed areas of Canada, offering access to high-quality soil, favorable climate, water and a local market of 2.5 million people. Agriculture in this region yields an annual economic value of more than $3 billion.

The closing date for the transaction is slated for September 4, 2020, after a 51-day due diligence period. According to Elliott, the addition of such a significant package of land is a major step for Pac Roots.

“This land has no zoning restrictions and is not situated within the agricultural land reserve, which provides for infinite development possibilities,” Elliott added in a July 2020 news release.

Board of Directors member Chad Clelland also welcomed the acquisition, adding that between Fraser Valley and Rock Creek – both of them among the most productive agricultural regions in Canada – Pac Roots is very well positioned for production and the future development of its hemp and cannabis infrastructure.

The RAD Americas Genetic Program – Research and Development in Americas Genetic Program

Pac Roots intends to deploy a global R&D program focused on rigorously testing elite strains in various rich agricultural regions throughout the Americas, with a goal of mass selection to achieve the utmost environmental resilience while achieving notable quality and yields. From seed to software, collection data, proprietary techniques and custom nutrient formulas, Pac Roots and Phenome will provide the specific knowledge to cultivators in different climates in order to achieve optimal yields for THC, CBD, CBG and other unique cannabinoids. R&D from global testing programs situated throughout the Americas will allow the partnership to deploy and stress test a range of suitable cultivars in the world’s lowest cost outdoor growing regions.

The company expects an industry shift in 2020 from the COVID-19 global pandemic. The ‘new normal’ will bring more focus on efficiencies and optimal yields to deliver a cost effective, high quality product to the end user. There has been much to be learnt from the inefficiencies in the cannabis industry in recent years, which have been detrimental to the credibility of the sector. Pac Roots is well positioned to enter the scene and take advantage of the deficiencies, reinforcing the notion that genetics and flawless growing techniques are paramount to success. Genetics and systems innovation may be the most overlooked components when comparing cannabis to other established agricultural crops. Pac Roots plans to invest into cannabis R&D to ensure a solid foundation is built that will be used by cannabis farmers worldwide.

Through its RAD Americas Development and Innovation, Pac Roots is focused on:

  • Deploying one of the largest live genetic libraries in Canada, diversified for high yield output and unique climates
  • Continued stress testing for indoor, high yield, THC and medicinal genetics
  • Continued stress testing for outdoor, high yield, THC and medicinal genetics
  • Exotic, genetic cloning for the luxury, high margin, cannabis flower market
  • Psychoactive/medicinal ratio testing for effect and
  • Unique Cannabinoid and terpene elevation and isolation.

Through its RAD Americas Field Testing System, the company is focused on:

  • Global testing in different microclimates to assess genetic and complete systems for optimal yields
  • Data collection, testing and optimization to prove process for commercial implementation and
  • High quality yield testing for THC, CBD, CBG and other unique medicinal cannabinoids.

Lake Country Cultivation Facility near Kelowna, British Columbia

Pac Roots is in the process of completing its 20,000 square foot cultivation facility in Lake Country, British Columbia. The facility is expected to feature approximately 7,600 square feet of cultivation space that will enable the company to cycle through its line of high-grade cultivars. Pac Roots plans to submit a video evidence package of the facility build under Health Canada’s Cannabis Tracking and Licensing System, and the company expects to acquire its cultivation license in the fourth quarter of 2020.

Lake Country is a municipality located just outside of Kelowna in the Okanagan region of British Columbia. For decades, the region’s favorable growing climate has made it a hub for cannabis cultivation. As the Canadian legal cannabis industry ramps up, the Okanagan region is attracting attention from dozens of cannabis companies, including some of the industry’s biggest names. The region’s strong agricultural history has left it rich with experienced agricultural workers and an abundance of Agricultural Land Reserve (ALR) property.

Management Team

Patrick Elliott, MSC, MBA, President and CEO of Pac Roots Cannabis, is also the President & CEO of Lexore Capital Corp., a private resource and cannabis investment company, as well as Phenome One Corp., a full-service cannabis farming company focused on elite strain selective breeding. Elliott brings over 15 years of corporate finance, mineral exploration and financial markets experience to the Pac Roots team. He is a graduate of the University of Western Ontario in geology and holds an MSc. in mineral economics and an MBA from Curtin University of Technology in Perth, Australia. Elliott specializes in economic resource evaluation, financial modeling, CAPEX estimation, corporate development and finance. Combined with his technical knowledge, Elliott has a wealth of contacts in the financial sector.

Marc Geen, Founder and Strategic Operations Advisor, is a fourth-generation British Columbia farmer who has been active in the legal medical marijuana industry for more than 10 years – consulting on, complying with, and participating in the MMAR, MMPR and ACMPR programs. Prior to co-founding Speakeasy Cannabis Club Ltd., Geen spent 14 years as Head of Operations for Kettle Mountain Ginseng Ltd., one of North America’s largest ginseng producers. With the experience gleaned from a long career in large scale commercial farming, Geen has been able to apply many cost-effective farming practices to the outdoor, indoor and greenhouse cultivation of cannabis. Geen is also the co-creator of a full line of cannabis extract products designed under ACMPR regulations.

Matt McGill, Director, has a strong background in both commercial and residential real estate and has played a major role in many development projects. McGill, through McGill Realty, has established a tremendous commercial and residential outfit servicing British Columbia’s Fraser Valley and the lower mainland. McGill is skilled at crafting strategic financing options for corporations and has a substantial network of retail and institutional clients.

Chad Clelland, Director, has experience in the sector dating back to 2009, when he purchased Medicalmarijuana.ca, which became an information portal for thousands of patients, doctors and growers. Through this company, he and his team have helped thousands of Canadians find legal, safe medication. His team also consulted, designed and submitted dozens of applications to the government under the MMPR, ACMPR and Cannabis Act. In 2011, Clelland co-founded Greenleaf Medical Clinic, which is now recognized as a training facility by the University of British Columbia and offers preceptorships to physicians, nurse practitioners and pharmacists. He also co-founded Folium Life Science in 2013, an approved Canadian Licensed Producer. His roles in these organizations have included Chief Operating Officer, head of security, alternate master grower and alternate responsible person in charge.

Josh Bromley, Senior Cultivation Strategist, is a second-generation farmer with over two decades of experience farming, breeding, cultivating and selecting unique cultivars for the medical community. He is an expert in plant science and possesses a comprehensive knowledge of cultivars and a mastery of medicinal implementation. Bromley has developed proprietary farming systems, as well as low cost/high output nutrient systems. Through thoughtful design and engineering, he has been able to consistently show improvements in crop yields, pathogen resiliency and quality.

Pac Roots Cannabis Corp. (PACR), closed Wednesday's trading session at $0.29, 16.00%, on 1,150 volume with 2 trades. The average volume for the last 3 months is 28,319 and the stock's 52-week low/high is $0.11/$0.72.

Recent News

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA), a leader in online vehicle transactions using smartphones, has announced an agreement with HUB International Ltd. ("HUB"), the largest privately held, personal-insurance brokerage in the country. As part of the agreement, HUB’s personal lines of automotive insurance solutions will be available on PowerBand's virtual transaction platform to drivers in the United States initially, with plans to expand to Canada soon. To view the full press release, visit http://nnw.fm/I8PlA

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÃœV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Wednesday's trading session at $0.186, up 5.5319%, on 18,960 volume with 7 trades. The average volume for the last 3 months is 83,104 and the stock's 52-week low/high is $0.038600001/$0.241600006.

Recent News

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B)

The QualityStocks Daily Newsletter would like to spotlight Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B).

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) was featured today in a publication from MiningNewsWire, examining how, as several Americans are contemplating on mining, they usually think of their past. The Americans invented the old 1840s mine, which has been helping them to date. However, mining ought to help one think more regarding the future. It will assist you in adapting to the high-tech era. Modern technology also plays a vital role in controlling safety equipment and automated production. The high tech products will assist you in learning more regarding transformation since they rely on modern mining.

Bullfrog Gold Corp. (the “Company”) (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) is a Delaware corporation engaged in the acquisition, exploration and development of gold and silver properties in the United States. The Company controls strategic lands with established 43-101 compliant resources in one of the most exciting gold exploration areas in the United States. The Bullfrog Gold Project (“Project”) includes a lease/option on much of the lands where Barrick Bullfrog Inc., a subsidiary of Barrick Gold Corp., produced more than 2.3 million ounces of gold and 2.49 million ounces of silver from 1989 to 1999. The Project is located within the prolific Walker Trend about 125 miles northwest of Las Vegas, Nevada.

Project Highlights

  • The Company initially acquired 79 unpatented claims and two patents in mid-2011 and has since staked, leased, optioned, or purchased lands that now total 5,250 acres. Via a 2015 lease/option with Barrick, the Project includes the northern one-third of the Bullfrog deposit where most of the current resources in the Bullfrog mine area occur, along with their interest in the Montgomery-Shoshone deposit which gave the Company 100% control.
  • In mid-2017, a NI 43-101-compliant report by independent mining consultancy Tetra Tech Inc. estimated measured and indicated (“M&I”) resources of 624,000 ounces of gold and 1.73 million ounces of silver at average grades of 0.70 g/t and 1.93 g/t, respectively. The expansion plans of these two pits were based on a $1200 gold price, use of heap leach processing, and also included 110,000 ounces of inferred gold resources averaging 1.20 g/t. Barrick used conventional milling to process an average gold grade of 3 g/t.
  • The established resources and exploration potential of the Project are strongly supported by a large data base obtained from Barrick, including detailed information on 155 miles of drilling in 1,262 holes in the Bullfrog mine area.

Gold Rush in the Bullfrog Territory

The area around Beatty, Nevada has now attracted AngloGold Ashanti, Kinross Gold, Corvus Gold, Coeur Mining as well as the Company and Waterton. In this regard, Northern Empire Resources Corp’s property located a few miles east of the Project was acquired by Coeur Mining in October 2018 for C$117 million, implying a valuation of C$134/oz of inferred resources. As of today, the Company is trading at a significant discount to the valuation at which Northern Empire was purchased (http://nnw.fm/9NaaN), thereby highlighting the Company’s value proposition for investors.

Bullfrog Gold Corp. is focused on enhancing shareholder returns by concurrently advancing Project development and performing exploration drilling programs on several targets identified by the Company.

Secured Financing for 2020 Operations

Bullfrog Gold Corp. raised C$2 million in January 2020 through a private placement of shares priced at C$0.13/share plus a one-half warrant exercisable within two years at C$0.20 on a full warrant basis. The raise was carried out primarily to fund a drill program that started on May 1 (http://nnw.fm/6nZ0m), and was completed on June 6, 2020. Results from drilling 12,520 feet in 25 holes will be released in the coming weeks. The Company subsequently intends to conduct a preliminary financial analysis and complete further drill programs to advance the Project and add value. The financing was subscribed by several influential shareholders, including a former director of Northern Empire, who handled the sale of the company to Coeur Mining, and Eros Resources, the management of which has been involved with several high-profile mining projects and sales in the past.

Gold Prices estimated to average $1,800/oz in 2021

Gold prices have been on a remarkable run in 2020, rising by $245/oz to $1,760 prior to peaking in early May. Global central banks carried out 144 interest rate cuts thus far in 2020, reducing their rates by a cumulative 5,035 basis points (http://nnw.fm/jzZt0). Meanwhile, the IMF has estimated that global governments have introduced fiscal support measures amounting to over $9 trillion since the start of the COVID-19 pandemic (http://nnw.fm/Or9rI). The resulting weakness in the U.S. dollar and eventual inflationary pressures stemming from these measures prompted Credit Suisse to recently hike their gold price forecasts for the full year to $1,701/oz (from $1,570 previously), while the outlook for 2021 has been raised to $1,800/oz (versus $1,600 previously) (http://nnw.fm/Iqg0X).

Management Team

David Beling, CEO, President and Director
David Beling is a Registered Professional Mining Engineer with 55 years of diverse experience in areas such as engineering, development, permitting, construction, financing and management of mines and plants and the building and growth of several corporations. His initial employment included 14 years with Phelps Dodge, Union Oil, Fluor, United Technologies, and Westinghouse, followed by 41 years of senior management and consulting with 25+ U.S. and Canadian mining companies. In 2006-2007, he spearheaded an IPO, successfully drove equity raises totaling C$112 million and grew that Company’s market capitalization to $460 million. Beling has served on 14 boards since 1981, including three mining companies distinguished by the TSX Venture Exchange as top-10 performers.

Alan Lindsay, Chairman of the Board
Alan Lindsay is an entrepreneur and businessman who has founded seven companies within the mining and pharmaceutical industries, including Anatolia Minerals Development Ltd., Uranium Energy Corp., Oroperu Mineral, Strategic American Oil and AZCO Mining. Lindsay also developed the strategic vision for the 2011 acquisition and placement of the Project from NPX Metals into Bullfrog Gold Corp.

Kjeld Thygesen, Director
Kjeld is a graduate of the University of Natal in South Africa and has 48 years of experience as a resource analyst and fund manager. In 1972, he joined James Capel and Co. in London as part of its highly rated gold and mining research team before subsequently becoming manager of N. M. Rothschild & Sons’ commodities and Natural Resources Department in 1979. In 1987, he became an executive director of N. M. Rothschild International Asset Management Ltd., before co-founding Lion Resource Management Ltd., a specialist investment manager in the mining and natural resources sector, in 1989. Thygesen has been a director of Ivanhoe Mines Ltd. since 2001 and served as investment director for Resources Investment Trust PLC from 2002 to 2006.

Tyler Minnick, CFO and Director of Administration & Finance
A registered member of the Colorado Society of Certified Public Accountants with over 24 years of experience within the fields of accounting, auditing, and administrative services. Minnick has been engaged with the Company since mid-2011 and previously worked in the finance department of MDC Holdings/Richmond American Homes, one of the largest residential construction companies in the United States.

Bullfrog Gold Corp. (OTCQB: BFGC), closed Wednesday's trading session at $0.15, up 5.5595%, on 141,740 volume with 49 trades. The average volume for the last 3 months is 241,621 and the stock's 52-week low/high is $0.047449998/$0.209999993.

Recent News

Kingman Minerals Ltd. (TSXV: KGS)

The QualityStocks Daily Newsletter would like to spotlight Kingman Minerals Ltd. (TSXV: KGS).

Kingman Minerals (TSX.V: KGS), a Canada-listed gold miner with extensive claims in key mining jurisdictions spanning North America, is positioned to leverage market trends as gold prices soar to record highs and investors look for a safe haven from inflation and the weakening of fiat currencies. To view the full article, visit http://ibn.fm/OABjh

Kingman Minerals Ltd. (TSXV: KGS), formerly Astorius Resources Ltd., is engaged in the acquisition, exploration and development of gold and silver properties in North America. The Canada-based company is focused on sourcing and developing high-quality properties in favorable mining locations to advance its diverse portfolio of low-cost, lifelong assets.

Kingman Mine

The Company maintains the following projects:

The Mohave Project: Located in the Music Mountains in Mohave County, Arizona. Approximately 35 miles from the town of Kingman, the property consists of 20 lode claims, including the historic Rosebud Mine. The Company has entered into an option agreement to earn 100% over four years. According to historic mappings of the mine, probable ore is 15,560 tons. Possible (inferred) ore is comprised of 176,000 tons, and additional possible (inferred) ore totals slightly over 1,100,000 tons. The total contained gold ounces for all categories is estimated at 664,000 ounces, and contained silver is estimated at 2,600,000 ounces. The Company has recently completed two underground reconnaissance and sampling programs and is in the process of verifying previous resource estimates.

 

The Cadillac East Property: Located approximately 55 kilometers east of Val d’Or, a hub for exploration and mining activities in the Canadian province of Quebec. The Company acquired a 100% interest in the property from an arm’s length vendor. Cadillac East Property consists of 12 claims, and the Company has an option agreement to earn 100% over three years. Having been the subject of numerous geophysical and geological surveys, the Cadillac East Property has been explored and surveyed by numerous companies as well as by the Quebec government. Exploration work done in 2017 by Exploration Facilitation Unlimited Inc. revealed multiple potential targets for future investigation, as results from the soil program identified value in gold, silver, copper, zinc and nickel.

Kingman Minerals is focused on enhancing shareholder value as it continues exploring potential assets and acquiring strategic gold targets. The company recently commissioned mining consulting services company Burgex Mining Consultants Inc. to complete two underground gold exploration programs in the historic Rosebud Mine. Burgex specializes in mineral exploration, mining claim staking, landman services, mining consulting, and the access and documentation of abandoned mine sites throughout the western United States and the world. Burgex’s founders have been active in the industry since 2007 and have identified, secured and consulted on hundreds of thousands of acres of mineral properties spanning a wide range of mineral commodities with billions of dollars’ worth of resources and reserves. The Burgex team has been featured in Forbes Magazine as well as on the Discovery Channel and other outlets. Burgex is at the vanguard of industry advancements in safely accessing difficult vertical abandoned mine workings and continues to pioneer new mineral exploration methods with strategic partners throughout the United States and the world.

Gold’s Predicted Rise

The value of gold is currently on an upward climb due to COVID-19’s upending of the global economy, causing governments to expand their balance sheets. In 2019, as a result of the housing and financial crisis, gold saw its best performance since 2010 — increasing as much as 20% and hitting a top price of $1,549 per ounce in September of that year. Analysts predict its price will continue to climb due to strong buying by central banks, a weakening of the U.S. dollar, and increasing political tensions. A recent Wolfe Research report predicted gold would hit an all-time high, referencing an ounce of gold that commanded a $1,515 asking price. As the value of the U.S. dollar weakens, the demand for gold is inversely rising. Known as a safe-haven asset, gold tends to see increased levels of demand during times of consumer fear or recession.

Management

Sandy MacDougall – Chairman and Director
An economics graduate from the University of British Columbia, Sandy MacDougall brings 30+ years of experience in the investment banking and finance industry to KGS. He was instrumental in the acquisition, development and production of gold at the Alto el Toro mine near Ibaguel, Columbia. As a former investment advisor at Canaccord Capital Corp., MacDougall was a key player in multiple significant financings in Canada as well as abroad, working with a wide range of companies. His experience has afforded him critical exposure to precious and base metal projects throughout North and South America, and he has served as chairman of the board since 2016.

Arthur Brown – President and Director
With 36 years of business experience and service to the boards of eight other companies in sectors ranging from technology to oil, gas and mineral exploration, Arthur Brown adds substantial knowledge in corporate structure and development as well as financings and venture capital to the KGS team.

Cyrus Driver – Independent Director
Cyrus Driver was a founding partner in the firm of Driver Anderson from its inception in 1982 and is a chartered accountant as well as a retired partner in the firm of Davidson and Company LLP. Aside from providing general public accounting services to a diverse range of clients, his specialty is servicing TSX Venture-listed companies and members of the brokerage community. With expert knowledge of the securities industry and its regulations, Driver lends valuable advice to his clients regarding finance, taxation and other accounting-related matters. He currently serves as director and chief financial officer of several TSX-V-listed companies.

Dr. Peter Born – Director and Technical Specialist
A professional geologist registered with the Association of Professional Geoscientists of Ontario and a fellow of the Geological Association of Canada, Dr. Peter Born brings 30+ years of experience in exploration and mining to the company. With prior roles as a senior geologist with Western Mining Corporation, he is currently working with RPS Energy Canada Ltd. on natural gas plays related to high-temperature dolomites and sedimentary zinc deposits (MVT) within the Appalachian Basin in the United States. Dr. Born holds a Ph.D. in earth sciences and has expertise in Precambrian sedimentary geology, basin analysis, sedimentology, stratigraphy and sedimentary ore deposits.

Kingman Minerals Ltd. (TSXV: KGS), closed Wednesday's trading session at $0.115, up 4.55%, on 108,500 volume with 10 trades. The average volume for the last 3 months is 116,242 and the stock's 52-week low/high is $0.07/$0.23.

Recent News

DarioHealth Corp. (NASDAQ: DRIO)

The QualityStocks Daily Newsletter would like to spotlight DarioHealth Corp. (DRIO).

DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, has recently achieved a series of successes and anticipates even more in the coming weeks. Among drivers of DRIO’s path toward leading cutting-edge solutions is the global pandemic, which has unveiled dynamics of the company’s business model that provide distinction in an era in need of next-generation health care. To view the full article, visit: http://ibn.fm/uYNu1

New York and Israel-based DarioHealth Corp. (NASDAQ: DRIO) leads global digital therapeutics (DTx) with its popular, smartphone-centered personalized chronic illness management software-as-a-service (SaaS). The company’s strategic advantages include:

  • AI-powered digital solutions that drive durable behavior change in chronic disease patients, and
  • Personalized user experience at scale to make behavior change the path of least resistance.

Approximately $3 trillion in annual U.S. costs associated with chronic illnesses like diabetes, hypertension and obesity are largely preventable with behavioral therapies. Formerly limited to periodic office visits, these therapies can now scale to millions with tech-enabled, continual and remote health monitoring, as well as AI-driven digital and live coaching. This is all possible while still maintaining the personalization required for success in reducing illness and its related effects and costs.

Roughly 51,000 active, paying users manage their health with Dario’s platform that combines smartphone-connected vitals measurement, remote patient monitoring (RPM), lifestyle management tools, and AI-driven and human coaching to deliver improved clinical outcomes.

Among the most downloaded medical apps, the Dario platform is rated at 4.9 stars on the Apple App Store and features 11,000 reviews, along with a Net Promoter Score (a measurement of consumers’ willingness to recommend the product to others) that’s the highest in its field.

Company Strategy

Clinical studies demonstrate Dario’s direct improvement on users’ health measures like H1AC scores (diabetes) and blood pressure (hypertension).

Patient engagement in therapies leads to health success. Dario’s platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices.

Proprietary data analysis provides valuable insights that not only improve health care providers’ medical capabilities but, through artificial intelligence, encourage patients to take evidence-based and highly personalized preventative measures that reduce risk, emergency room visits and preventable hospitalization.

Dario is now deploying its successful B2C platform in B2B2C, targeting employers and health plans with competitive advantages in cost, software and hardware.

The company estimates an annual addressable U.S. market of $72 billion, only 1% of which has been penetrated with digital therapeutics.

The strategic transition to B2B2C (from exclusively B2B) is intended to accelerate revenue growth by reducing Dario’s cost per acquisition per user and expanding margins.

Dario’s commitment to aggressive growth is also shown by its appointment of a new president, chief medical officer and head of sales for North America, all from a highflyer behavioral health company.

Key growth drivers planned include expansion of the company’s paying B2C subscriber base; lateral expansion into other chronic conditions that overlap with its core diabetes populations, such as hypertension, obesity and depression; and increased B2B2C penetration.

Financial Highlights

The company plans to leverage a massive opportunity for growth, with a global addressable market for digital therapeutics of roughly $108 billion. In the U.S. alone, that number is estimated at $72 billion, and only about 1% of that market has been penetrated.

Dario’s strategic transition to an SaaS membership business model increased gross profit by 87% in Q1 2020, as compared to the prior year. Membership revenue increased from 27.1% to 46.7% in the same period. The company is seeing improved operating efficiencies as it shifts focus to the B2B2C business model, and it expects average revenue per user per month (ARPU), which was $6 and $25 in 2019 and 2020, respectively, to reach $70.

Value to Consumers and Businesses

Dario continually evaluates and optimizes the value and return its platform delivers to consumers and businesses.

Consumers seeking to understand how their everyday behavior impacts their personal health and chronic conditions benefit from actionable feedback on how to improve health and better collaborate with health care providers.

Businesses looking to increase employee satisfaction, loyalty and productivity with fewer health-related absences take advantage of Dario’s services for employers.

Health care providers improve patient compliance using the platform’s interactive services that allow for greater monitoring, which improve engagement with patients at the right times and with the right treatments.

Health plans can leverage DarioHealth’s solutions to improve patient outcomes and lower costs.

Recent Studies

The company recently presented the results of two new studies at the American Diabetes Association’s 80th Scientific Sessions, which showed sustained improvements in blood glucose levels and blood pressure among users of its digital therapeutic platform for chronic diseases. The results of these two studies demonstrate that the use of Dario’s therapeutic platform promotes behavioral modification, enhanced individual engagement and improved clinical outcomes.

Remote Patient Monitoring (RPM) Agreements

The Centers for Medicare & Medicaid Services recently approved RPM codes for Medicare patients, which enables physicians to bill for between-visit patient care.

This simplifies implementation of the company’s open and scalable AI-driven platform and further supports transition to the company’s high-margin, recurring SaaS model targeting B2B2C revenue channels.

Emergency COVID-19 FDA Guidelines Allow Self-Test Blood Glucose Meters

In an effort to preserve personal protective equipment (PPE) and reduce contact between health care providers and patients in hospital settings due to COVID-19, the U.S. Food and Drug Administration (FDA) has recognized that home-use blood glucose meters, including Dario’s smartphone-connected metering device, may be used by patients with diabetes who are hospitalized due to COVID-19 to check their own blood glucose levels and provide the readings to the health care personnel caring for them.

As a result, hospitals can now allow patients to self-test using their Dario blood glucose testing strips and smartphone-connected devices, or hospitals can issue patients Dario devices upon admission for COVID-19-related conditions.

Irregularities in blood glucose levels are suspected as a factor in the increased severity of potentially deadly COVID-19 complications. As such, a high priority is being placed on stabilization of patients’ blood glucose levels.

Awards and Recognition

DarioHealth’s Blood Glucose Monitoring System was voted as the ‘Best Glucometer for Data Management’ by Top Ten Reviews. Jeph Preece, senior editor at Top Ten Reviews, said, “The Dario app is the best data management system that I’ve seen. Compared to apps by popular brands, Dario’s system looks and feels like it’s years ahead of the curve.”

‘The Global Digital Health 100’, an annual award sponsored by the reputable Journal of Health, recognized DarioHealth as a leader among health technology companies demonstrating the greatest potential to change the way that health care is delivered.

DarioHealth Corp. (DRIO), closed Wednesday's trading session at $16.25, up 4.4344%, on 103,544 volume with 696 trades. The average volume for the last 3 months is 256,164 and the stock's 52-week low/high is $3.01999998/$22.4899005.

Recent News

Mobius Interactive Ltd.

The QualityStocks Daily Newsletter would like to spotlight Mobius Interactive Ltd..

Mobius Interactive, an online gaming operator with a variety of unique offerings catering to diverse demographic groups, is gearing up for an official launch in early September. In preparation for that milestone moment, the company has released key information about its three distinct brand offerings and a glimpse at what sets the company apart in what is forecast to be a billion-dollar industry in 2021.

Mobius Interactive Ltd. is an online gaming operator launching in September 2020 with a variety of unique offerings catering to diverse demographic groups. In partnership with Ultra Play, a leading eSports and iGaming platform, Mobius Interactive is seeking to attract a network of high-net-worth gamers from around the world through the use of loyalty and gamification programs designed to enhance customer engagement by leveraging state-of-the-art customer relationship management systems and joint-ventures with over 600 VIP and Master gaming affiliates.

Array of Brands

Mobius Interactive is seeking to target a variety of customer segments and geographies through its diverse brand offerings, including:

  • Aragon Casino: Austria, Finland, the Balkans, Canada, Africa and New Zealand
    Catering to consumers aged 21 to 45, Aragon Casino brands itself along the lines of medieval fantasy, mimicking elements from the likes of The Walking Dead and Game of Thrones.
  • Club Double: Austria, India, Brazil, Finland, Canada, Africa and New Zealand
    Targeting the 30 to 65 age demographic, Club Double is designed to exude a classic yet magical old Hollywood and vintage Miami & Las Vegas air.
  • MobiusBet: Germany, Austria, Switzerland, Brazil, Latin America, New Zealand and India
    MobiusBet is designed to appeal to the 18- to 38-year-old eSports community, bringing together loyalty programs, targeted gamification and product merchandising in one seamless package.

Key Differentiating Indicators

Mobius Interactive has designed its platform with a number of key differentiation traits relative to its target market. These include:

  • The use of affiliates: Mobius Interactive has partnered with over 600 VIP and Master gaming affiliates, who will introduce high-value players to the company’s award-winning iGaming platform. Mobius added over 150 proven affiliates in Europe, Brazil, Finland and New Zealand over a period of just 20 days.
  • eSports Focus: Mobius.Bet, Mobius Interactive’s dedicated eSports hub, will cater to the quickly growing eSports segment, which is expected to rise to a value of $1.7 billion in 2021. With Mobius’ COO being one of the original founders of the eSports.com brand, the company aims to capitalize on this growing segment of the gaming industry.
  • Customer Relationship Management (CRM): Mobius has partnered with Solitics, a new and real-time CRM system, enabling the company to personalize customers’ gaming experiences in an interactive and highly intelligent manner.
  • Loyalty & Gamification: Mobius Interactive is set to introduce a unique loyalty and gamification program designed to increase customer engagement from signup. Loyalty and gamification programs have been proven to increase daily active wagering volumes by 30% while simultaneously increasing daily player activity by 60%. Furthermore, the introduction of these programs can help lower the company’s customer acquisition costs while adding a differentiating element to its platform.

Partnership with Puurl

Puurl provides a solution that embeds eGaming platforms into any existing online e-commerce store. First, shoppers can install the Puurl add-on to their browsers. Then, when visiting their preferred e-commerce stores, players will be prompted to bet, with the potential to win the products they’re browsing. The Puurl solution enables e-commerce operators and eGaming platforms to earn additional gambling revenues – even when their players are shopping. Through its partnership with Puurl, Mobius Interactive will look to add a unique revenue stream to complement its core business operations.

Management Team

Lynn Pearce, CEO, is an experienced, data-driven, commercially focused, strategic brand marketer with over 15 years of proven success in the global gaming industry, from land-based casinos in the UK to online gaming companies offering sports betting, poker and casino games. She was head-hunted to join a startup in Prague that launched 26 casinos, becoming profitable within the first three months of operation, before she relocated to Malta to join a leading B2B casino software development company as head of marketing, where she led global marketing, PR, product development, branding and go-to-market campaigns, retaining full control of a six-month budget of €1 million to increase brand awareness and customer engagement. She recently returned to the B2C side of gaming to launch three new brands in Germany, Brazil and India. She writes articles regularly for Infinity Gaming Magazine and has been a judge for the prestigious International Gaming Awards, a significant event for the gaming industry held each year prior to the largest gaming exhibition of the year, ICE London.

Robin Lawson, Vice President & COO, has been involved in iGaming for over 10 years, successfully founding two VIP casino departments across international locations in Latin America, as well as startup company Tabella in Europe. He most recently co-founded and acted as COO for eSports.com, which raised over $5.5 million as a startup ICO and was sold to German media giant ProSieben. Lawson is also a senior iGaming consultant for startup casino groups and an advisor to blockchain-based tech groups. His long-time experience and proven track record in startup organizations demonstrate his operational leadership skills.

Nicholas de Freitas, Vice President, Marketing, is one of the pioneers of digital stills photography for major retail companies in Africa and Australia. He left to start up UrbanActive, an outsourcing agency, working as marketing project manager and implementing major retail projects. He received his certification in digital marketing from the University of Stellenbosch. He has worked over the past few years as the marketing manager for various poker rooms and casinos, liaising and building relationships with software developers, successfully implementing a number of casino and poker products and holding regular weekly report sessions with the heads of all divisions of the company, spanning South Africa, Canada, Malta, Norway and Costa Rica.

Gary Eldridge, Chairman, is an experienced entrepreneur with a history of working in the venture capital and private equity industry. He is skilled in capital markets, M&A and funding startups and is a strong business development professional. For the past 30 years, he has created and managed numerous public and private companies in Canada, the U.S., Amsterdam, London, Zurich, Dusseldorf, Singapore and Panama. In addition to holding the role of chairman of the company, Eldridge is acting as a mentor to the team, assisting with the financials and structure of the company while allowing the team to be fully focused on Mobius’ growth and operations.

Recent News

chart

Cybin Corp.

The QualityStocks Daily Newsletter would like to spotlight Cybin Corp..

Cybin Corp., a life-sciences company advancing psychedelic pharmaceuticals, has announced that Doug Drysdale has been appointed as CEO. With more than three decades of experience, Drysdale brings invaluable insight and expertise to his new role. In 2014 as a corporate director of a NASDAQ-listed pharmaceutical company, he led the company’s recapitalization efforts, raising an estimated $65 million. Consequently, he was appointment chairman and CEO and revamped the company’s management team and board of directors while also building a 220-person sales team — all within the first year. To view the full press release, visit http://ibn.fm/KJ7X0

Cybin Corp. is a Canada-based life sciences company focused on the pharmaceutical development of psychedelic products, as well as the functional mushroom market.

The early-stage company boasts an experienced management team featuring industry veterans from pharmaceutical and consumer product backgrounds who have run multiple clinical trials and collectively helped facilitate billions of dollars in product revenues. The team is dedicated to the development of products and protocols within the psychedelic, pharmaceutical and nutraceutical industries.

In particular, Cybin aims to further build upon and expand its intellectual property (IP) portfolio, which is structured around unique psilocybin delivery mechanisms that target a number of different therapeutic indications. In addition, the company has dedicated itself toward furthering its research and IP within the fields of synthetic compounds, extraction methods, the isolation of chemical compounds, new drug formulations and protocol regimes.

Serenity Life Sciences & Natures Journey Inc.

The company’s business model is centered around its two core subsidiaries, Serenity Life Sciences and Natures Journey Inc., which comprise Cybin’s two-pronged approach toward delivering fungi-derived psychedelic and medicinal products.

Serenity Life Sciences is focused on furthering research and development of psilocybin-based medications. Psilocybin is found in certain species of mushrooms and is a non-habit forming, naturally occurring psychedelic compound. Research into psilocybin has shown positive results for the treatment of depression, anxiety, PTSD, addiction, eating disorders, ADHD and other indications.

Natures Journey Inc. operates the Journey brand, which specializes in developing proprietary medicinal mushroom products that target and promote mental wellness, immune boosting detoxification and overall general health and wellbeing.

Partnership with the Toronto Centre for Psychedelic Science (TCPS)

Staying true to its axiom of being a research-first medicinal mushroom life sciences company, Cybin recently announced its entry into a strategic partnership with the Toronto Centre for Psychedelic Science (TCPS), with the goal of furthering its ongoing psilocybin research efforts and expanding Cybin’s psilocybin IP portfolio (http://nnw.fm/9EUkI).

“While there is evidence to support psilocybin as a treatment for certain indications, the Toronto Centre for Psychedelic Science is taking a clinical approach to prove or disprove the safety and efficacy of psilocybin-based microdosing through an open science approach,” Paul Glavine, CEO of Cybin, stated in a news release.

“We are excited to join forces with Cybin and to offer our expertise. A number of firms had approached TCPS, but Cybin demonstrated a superior commitment to high-quality research and integrity in product development. Our high standards for scientific rigor and transparency will find a fitting home within the culture Cybin is cultivating in Canada and abroad,” Thomas Anderson, co-founder of the Toronto Centre for Psychedelic Science, added.

Journey’s Product Monetization & Market Potential for Nutraceutical Supplements

Although Cybin is at the forefront of companies seeking to conduct clinical trials aimed at gaining regulatory approval for psilocybin and other psychedelic products, the company has also placed a great deal of emphasis on generating meaningful revenue from its very outset.

Cybin’s Journey brand has is launching a range of supplements comprised of popular fungi-derived ingredients such as Reishi, Lion’s Mane and Cordyceps. Purported to aid focus and concentration while promoting neurogenesis, Journey’s range of nutraceutical products provides Cybin with a crucial foothold within the non-psychedelic legal supplement market, which is valued at over $25 billion globally and growing at a 9% year-over-year rate.

Pharmaceutical Psychedelics

In addition to the company’s range of non-psychedelic supplements, Cybin has plans to carry out a clinical trial with a new delivery system for its psilocybin-based medications later this year. Ultimately, the company aims to enter into technology transfer agreements with global pharmaceutical companies after phase 1 & phase 2 clinical trials are complete in order to accelerate regulatory approvals in major indications in global markets with entire lifecycle product management.

With products such as psilocybin truffles already legal in nations such as the Netherlands, Jamaica and Bulgaria, Cybin has positioned itself to capitalize on an eventual legalization of psychedelic mushroom-derived products in the future. Working within a regulatory environment with strong similarities to that which dealt with cannabis prior to the industry’s eventual legalization by the Canadian government in 2018, Cybin is laying the groundwork for the moment pharmaceutical psychedelics gain acceptance in North America and abroad.

Amalgamation Agreement and Financing

Cybin recently announced its entry into an amalgamation agreement dated June 26, 2020, with Clarmin Explorations Inc. (TSX.V: CX) and 2762898 Ontario Inc., a wholly owned subsidiary of Clarmin (http://nnw.fm/w04LH). Completion of the transactions contemplated in the amalgamation agreement will result in the reverse takeover of Clarmin by Cybin.

In connection with the proposed transaction, Cybin plans to complete a “best-efforts” brokered private placement of subscription receipts of Cybin, with a syndicate of agents co-led by Stifel Nicolaus Canada Inc. (Stifel GMP) and Eight Capital, to raise a minimum of C$14 million ($10 million) and a maximum of C$21 million ($15 million), with a 15% agents’ option.

To date, Cybin has raised approximately C$10,400,000 through an initial financing round and its series A financing round.


Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element (NASDAQ: NETE) was featured today in a publication from Green Car Stocks, examining how electric vehicles are poised to take over internal combustion-engine vehicles over the next decade in a bid to cut our reliance on carbon-based energy and reduce our impact on the planet. However, one thing that stands against widespread EV adoption, at least in Europe, is inadequate charging infrastructure. Aside from Tesla, most of the electric vehicles sold across Europe have to rely on an inadequate system of different and often broken down charging facilities.

On June 15, 2020, Net Element announced its entry into a binding letter of intent to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company, in a stock-for-stock reverse merger in which Mullen’s stockholders will receive the majority of the outstanding stock in the post-merger company. The proposed merger is currently pending the execution of a definitive agreement, shareholder vote and regulatory approval.

Net Element Inc. (NASDAQ: NETE) is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. The company’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element chairman and CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked on Deloitte’s Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in both 2017 and 2018, during which the company grew 190 percent and 183 percent, respectively. The company credits its progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

Net Element was also listed among South Florida Business Journal’s 2016 fastest growing technology companies.

Leveraging its suite of application performing interfaces (APIs) and connectors, Net Element powers commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Leading this innovation is chairman and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations like Aptito to e-commerce and retail payment transaction processing brands like Payonline and Unified Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed Wednesday's trading session at $6.85, off by 3.6568%, on 493,957 volume with 2,206 trades. The average volume for the last 3 months is 1,729,281 and the stock's 52-week low/high is $1.472/$20.0783996.

Recent News

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

It’s no longer a trade secret: Big data analytics are critical for success across almost every industry and particularly important for consumer-focused businesses looking to dial in their marketing efforts. The investment industry is no exception, and Sequire, a data analytics platform powered by SRAX (NASDAQ: SRAX), gives public companies an edge by providing the tools needed to monitor the activities of both retail and institutional investors while providing the critical data needed to successfully activate media campaigns, engaging current shareholders and attracting new investment.

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Wednesday's trading session at $2.84, off by 5.9603%, on 40,766 volume with 215 trades. The average volume for the last 3 months is 88,600 and the stock's 52-week low/high is $1.04999995/$3.28999996.

Recent News

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF)

The QualityStocks Daily Newsletter would like to spotlight GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF).

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF) (formerly Altum Resources Corp.), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, recently announced its entry into agreements to acquire seven advanced gold projects in the Maricunga Gold Belt of Chile that hosts over 100 million ounces of gold within the last 10 years.

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) (formerly Altum Resources Corp.), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, recently announced its entry into agreements to acquire seven advanced gold projects in the Maricunga Gold Belt of Chile that hosts over 100 million ounces of gold within the last 10 years.

Chilean Gold Properties Being Acquired

On April 17, 2020, GoldHaven Resources entered into an agreement to purchase a 100% interest in two gold projects located in the Maricunga Gold Belt of Northern Chile. The first property, Rio Loa, is located 25 kilometers south of Gold Fields Ltd.’s Salares Norte, where, this year, a five-million-ounce discovery was made. The second property, Coya, is located only 10 kilometers east of the Kinross La Coipa open pit mine, which has produced over 7.5 million ounces of gold to date.

Rio Loa Project

Initial geophysical studies of the Rio Loa site have exposed highly anomalous ardennite and lead values, a key characteristic of gold mineralization within silicified resistive bodies. The studies have also produced initial findings which are similar to those seen at contiguous mines, such as Salares Norte (operated by Gold Fields), which has over five million ounces in estimated gold deposits.

The potential economics for the site look particularly promising when taking the unit costs at the neighboring Salares Norte mine into account. Gold Fields has estimated that its production AISC (all-in sustainable costs) will approximate $552 per ounce and have forecast a 2.3-year payback period for its initial investment, assuming a $1,300 per ounce gold price.

Coya Project

The Coya site is located within close proximity to one of the richest and largest epithermal gold and silver districts in Chile and is in close proximity to active mining sites, specifically the La Coipa mine owned by Kinross. A study carried out in 2017-2018 on the Coya site of 796 rock chip samples found favorable gold and silver values, in some cases ranking as high as 764 grams/tonne of gold and 719 grams/tonne of silver – values which are near certain indicators of potential gold and silver deposits. The La Coipa mine (Kinross) has produced over 6.9 million ounces of gold to date.

On August 11, 2020, GoldHaven Resources acquired five potential gold projects in the Maricunga Gold Belt of Northern Chile. The Maricunga hosts discoveries within the last 10 years of over 100 million ounces of gold and over 450 million ounces of silver. These newly acquired properties are in close proximity to seven other mines, which possess an estimated aggregate of 81 million ounces of gold in total reserves.

GoldHaven’s five new projects cover a total area of approximately 22,600 hectares, or 226 square kilometers, located in the northern portion of the Maricunga Belt in proximity to the 5 million-ounce gold equivalent Salares Norte project owned by Gold Fields. Gold Fields announced in April 2020 its intention to proceed with the development of Salares Norte at a cost of $860 million, with a $138 million expenditure budgeted for 2020.

The Maricunga Belt extends approximately 150 kilometers north-south and 30 kilometers east-west, straddling the border between Chile and Argentina. This region hosts known mineral resources of more than 100 million ounces of gold, 450 million ounces of silver and 1.3 billion pounds of copper.

The Maricunga project’s opportunity came about as a result of a $150 million initiative launched by the Chilean Economic Development Agency (“CORFO”), with the objective of encouraging exploration and mining prosperity in Chile and strengthening Chile’s position as a world leader in the sector.

As part of CORFO’s program, a total of $15.3 million was given to private equity fund IMT Exploration to evaluate 403 projects, beginning in 2011. This led to a generative program carried out from 2016 to 2019, resulting in 126 potential epithermal targets from which 57 field evaluations were made. Due diligence work followed on 19 of these. Work programs were then conducted, including geological mapping, rock and soil sampling and TerraSpec (PIMA) analyses on geochemical grids for alteration mapping, and, as a result, the five high-priority Maricunga projects were identified. No drilling has been carried out on any of the Maricunga projects.

Securing Financing for Upcoming Operations

In conjunction with its announcement regarding its acquisition of five Chilean mining interests, GoldHaven Resources also detailed plans for a non-brokered private placement of 11.5 million units at a price of $0.35 per unit, for gross proceeds of $4,025,000. Each unit will consist of one share of the company and one warrant, the latter of which can be exercised to acquire an additional share of the company for a period of 18 months from the date of issuance at a price of $0.50 per share. Net proceeds from the offering are intended to be used to fund general expenses, as well as exploration and drilling of its mineral properties.

Gold Prices Hit Record High in 2020

Gold prices have been on a remarkable run in 2020, breaking above $2,000 per ounce for the first time on record. Having begun the year at $1,515 per ounce, the precious metal has seen a huge surge on the back of widespread economic uncertainty stemming from governments’ worldwide propensity to expand the money supply, from the reduction of the value of the U.S. dollar as expressed by the decrease in the U.S. dollar index, and from the very real economic effects of the COVID-19 pandemic.

Global central banks have carried out 144 interest rate cuts thus far in 2020, reducing rates by a cumulative 5,035 basis points (http://nnw.fm/jzZt0). Meanwhile, the IMF has estimated that global governments have introduced fiscal support measures amounting to over $9 trillion since the start of the pandemic (http://nnw.fm/Or9rI). The resulting weakness in the U.S. dollar and eventual inflationary pressures stemming from these measures has prompted a number of investment banks to boost their near-term outlooks for gold prices, with Bank of America raising its 18-month gold price target to $3,000 per ounce (http://nnw.fm/PQJtc).

Leadership Team

David Smith, President, CEO and Director, has been immersed in the mining industry for the last eight years, working in corporate development and finance. Prior to GoldHaven Resources, Smith cofounded a multifaceted real estate development and sales company, which has now been in operation for over 35 years. He also cofounded two successful environment-focused companies listed on the Toronto Stock Exchange. Both companies were sold independently and returned a significant profit for shareholders.

Darryl Jones, Chief Financial Officer, is a finance executive and CPA with over 30 years of public company and project buildout experience. Most recently, Jones served as the CFO of Lupaka Gold Corp., retiring in June 2018. Prior to that, Jones serves as CFO of Corriente Resources, which was sold to CRCC-Tongguan in May 2010 for C$680 million.

Patrick Burns, VP Exploration and Director, is a Canadian geologist with over 40 years of experience throughout the Caribbean and Central and South America. He played a direct role in the discovery of the Escondida porphyry copper deposit in Chile and has been involved in publicly traded mining companies, predominantly in Chile, for 35 years.

Marla Ritchie, Corporate Secretary, brings over 25 years of experience in public markets to the GoldHaven team. Throughout this time, she has worked as an administrator and corporate secretary specializing in resource-based exploration companies. Currently, Ritchie is the corporate secretary for several companies, including International Tower Hill Mines Ltd. and Trevali Mining Corp.

Gordon Ellis, Director; has over 50 years’ experience in mining and resource development. A professional engineer and entrepreneur, he has held multiple senior management and director roles with public mining companies, as well as a multi-billion-dollar ETF fund. Ellis holds an MBA in international finance and a Chartered Directors designation.

Scott Dunbar, Director is a professor and head of multiple departments at the University of British Columbia, including mineral extraction and mining innovation, as well as mining engineering. He has been involved in projects around the world in regard to mining exploration, geotechnical engineering and mine design. Dunbar received his PhD in geophysics and civil engineering from Stanford University.

GoldHaven Resources Corp. (OTCQB: ATUMF), closed Wednesday's trading session at $0.2527, off by 15.2866%, on 25,000 volume with 7 trades. The stock's 52-week low/high is $0.109999999/$0.446000009.

Recent News

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, has finalized development of a commercial version of its proprietary automation calibration software. In addition, the company announced that it has filed a patent application for calibration software for vision sensors intended to provide flexible placement of sensors on a vehicle while ensuring perception accuracy. The groundbreaking software offers continuous sensor calibration, which creates the stereoscopic 3D perception essential for safe and effective automotive stereo vision systems. Foresight’s pioneering technology provides automatic calibration between vision systems composed of multiple sensors, thus reducing the miscalibration that may happen when external factors cause the position of sensors to change. To view the full press release, visit: http://nnw.fm/s4X0j

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSightâ„¢. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSightâ„¢ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-Onâ„¢. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Netâ„¢. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Netâ„¢ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Netâ„¢ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed Wednesday's trading session at $0.9918, up 3.3125%, on 2,162,235 volume with 3,989 trades. The average volume for the last 3 months is 4,934,180 and the stock's 52-week low/high is $0.460999995/$1.95000004.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.